| From: Giants1967 | 9/6/2024 10:19:27 AM | | | | | | INTV Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market
Integrated Ventures Inc. (OTCQB: INTV), a holdings company, focused on e-commerce technology, digital assets and consumer-focused investments, is excited to announce (1) formation and launch of our second, fully funded, 100% owned subsidiary - MedWellDirect, LLC, Direct-To-Consumer (D2C) telemedicine solutions provider, mainly for weight loss and GLP-1 products and (2) acquisition of 51% stake in GetTrim.Com (TM), owned by Healthy Lifestyle USA – an innovative telemedicine weight loss services provider.
prnewswire.com |
| | Pennies Arent Dead | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: Giants1967 | 9/13/2024 11:20:36 AM | | | | | | SSII SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline
globenewswire.com |
| | Pennies Arent Dead | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| From: getlouied | 9/17/2024 10:21:23 AM | | | | | | $CBDL CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness
https://www.accesswire.com/918828/cbd-life-sciences-inc-unveils-groundbreaking-nutritional-supplement-infused-with-mushroom-extracts-set-to-drive-revenue-and-revolutionize-wellness
Projected to increase company revenue by 20% in the first year, capitalizing on the booming $18 billion wellness market.
SCOTTSDALE, AZ / ACCESSWIRE / September 17, 2024 / CBD Life Sciences, Inc. (CBDL), an innovative leader in the CBD wellness industry, is set to launch a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system.
Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being.
Unrivaled Benefits of Key Ingredients:
- Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today.
- Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity.
- Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery.
Revenue Projections & Market Potential
With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences, Inc.'s annual revenue. Analysts expect the market for mushroom-infused supplements to reach $18 billion by 2028, and with the unique blend of ingredients in this product, CBD Life Sciences, Inc. is poised to capture a substantial portion of that market. This launch is expected to drive a revenue increase of 20% within the first year, positioning the company at the forefront of the wellness supplement industry.
A Vision for the Future
Lisa Nelson, President and CEO of CBD Life Sciences, Inc., stated, "We are incredibly excited to bring this innovative product to the market. With the growing demand for natural, scientifically backed health solutions, we believe this supplement will be a game-changer, not only for our company but for the health-conscious consumers we serve." |
| | Pennies Arent Dead | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| To: Trumptown who wrote (38044) | 9/19/2024 10:38:05 AM | | From: Trumptown | | | | PYRGF - One of these days...to da moon!
finance.yahoo.com
PyroGenesis Congratulates its Client EarthGrid on its Joint Venture with EnerTech to Deploy US$18B in Plasma-Powered Tunnel Boring Projects
PyroGenesis looks forward to continuing to work with EarthGrid as it moves forward with its engineering, equipment procurement, and tunnel development projects.”
“PyroGenesis have been great supporters of our plan, both from a strategic and engineering perspective, as we readied the technology and financial approach over the past year,” EarthGrid founder Troy Helming said. “Having world-class plasma experts like PyroGenesis embracing our initiative and committing to us as a supplier means a great deal to us and our investors and we look forward to a prosperous long-term working relationship with Peter and his team at PyroGenesis.” |
| | Pennies Arent Dead | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last ReadRead Replies (1) |
|
| From: getlouied | 10/8/2024 1:56:08 PM | | | | | | $CBDL CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024
accesswire.com
"Record-breaking revenue, new market entries, and transformative partnerships highlight our path to increasing shareholder value and long-term growth."
SCOTTSDALE, AZ / ACCESSWIRE / October 8, 2024 / Dear Shareholders,
2024 has been a banner year for CBD Life Sciences, Inc. (CBDL), and we are thrilled to provide you with an exciting corporate update that underscores the massive growth and strategic advancements that are rapidly transforming our business. As of February 2024, we have achieved an extraordinary 1,405.46% increase in revenue, our highest to date, cementing CBDL as a dominant player in the booming CBD and wellness sectors.
This remarkable growth was driven by our aggressive expansion into new retail markets. By entering Amazon and Walmart Marketplace, two of the largest retail platforms globally, we have unlocked access to over $950 billion in combined annual consumer spending. This strategic move has resulted in a 300% growth in online sales since launch, and we're just getting started.
Our product line continues to drive exceptional demand. The launch of our Mellow Mornings nano CBD coffee creamers, along with our fast-acting pain relief cream, has resonated deeply with consumers looking for innovative, effective solutions. In fact, early sales data shows a 500% increase in unit sales for our nano CBD products alone, and our partnerships with local coffee shops have expanded our reach exponentially, with CBD-infused beverages seeing an average 40% increase in customer orders.
Our entrance into the cannabis market, through partnerships with key dispensaries, is expected to fuel additional revenue growth in 2025, with the cannabis industry projected to reach $73.6 billion by 2027. Our pipeline is filled with potential, and we anticipate these moves will unlock multi-million-dollar opportunities for CBDL in the coming quarters.
We are not just scaling, but we are scaling smartly, with a 40% increase in gross margins year-over-year, thanks to our focus on high-margin products and streamlined operations. Furthermore, we are on track to deliver continued triple-digit growth, with projected revenues for 2024 set to surpass $10 million, driven by product innovation and continued retail expansion.
For shareholders, this means an extraordinary opportunity to capitalize on one of the fastest-growing companies in the CBD space. The company has no intentions of doing reverse split. Our relentless focus on innovation, strategic market entry, and partnerships with leading retailers positions us to not only meet but exceed your expectations in the near future.
Thank you for your continued confidence and trust as we chart a course to even greater heights. |
| | Pennies Arent Dead | Stock Discussion ForumsShare | RecommendKeepReplyMark as Last Read |
|
| |
